LENSAR, Inc. (NASDAQ:LNSR) Q2 2023 Earnings Call Transcript
Operator: Good morning and thank you for your participation. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session.
Stay updated with breaking news from Dburns Mcclellan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning and thank you for your participation. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session.
ORLANDO, Fla.--(BUSINESS WIRE)--Aug 9, 2023--
- Brings more than 20 years of academic and industry experience with extensive expertise in kidney disease - WINSTON-SALEM, N.C., July 17, 2023 (GLOBE...
- Brings more than 20 years of academic and industry experience with extensive expertise in kidney disease -
SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the company’s Chief Scientific Officer, David Friend, Ph.D.,